Lilly to Go Solo with LY2605541

Lilly to Go Solo with LY2605541 – Analyst Blog

By: Stock Market News & Stocks to Watch from StraightStocks

Posted on January 11, 2013 at 16:15 PM EST

The company is adjusting its diabetes alliance with Boehringer Ingelheim and will re-assume sole worldwide development and commercialization rights to LY2605541.

Related Stocks:

AstraZeneca PLC ADS Bristol-Myers Squibb Co. Eli Lilly & Co. Johnson & Johnson Novartis AG ADS

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates